INIS
implementation
100%
viruses
100%
nanotechnology
100%
covid-19
100%
management
40%
patients
40%
diseases
40%
cytokines
40%
drug delivery
40%
lungs
40%
coronaviruses
40%
host
20%
tissues
20%
in vivo
20%
stem cells
20%
tools
20%
reviews
20%
regeneration
20%
pathogens
20%
clinical trials
20%
mutations
20%
size
20%
biological markers
20%
genetics
20%
nanostructures
20%
stimulation
20%
vaccines
20%
cargo
20%
reproduction
20%
maturation
20%
storms
20%
reticulocytes
20%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Coronavirinae
100%
Cytokine
66%
Disease
66%
Infectious Agent
33%
Nanocarrier
33%
Clinical Trial
33%
Drug Delivery System
33%
Immunogenicity
33%
Biological Marker
33%
Lung Infection
33%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Coronavirinae
100%
Exosome
100%
COVID-19
50%
Disease
20%
Cytokine
20%
Lung
10%
Pathogen
10%
Drug Delivery System
10%
Immunity
10%
Mesenchymal Stem Cell
10%
Biological Marker
10%
Reproductive Medicine
10%
Immune Response
10%
Cell Communication
10%
Maturation
10%
T Cell
10%
Clinical Trial
10%
Lung Infection
10%
Reticulocyte
10%
Nanocarrier
10%
Virus Replication
10%
Immunogenicity
10%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Exosome
100%
Coronavirinae
100%
COVID-19
50%
Cytokine
20%
Immunogenicity
10%
Viral Replication
10%
Mesenchymal Stem Cell
10%
Infectious Agent
10%
Maturation
10%
Immunity
10%
Immune Response
10%
Cell Communication
10%
Reticulocyte
10%
T Cell
10%